Examining the Business-Technology Alignment in Government Agencies: A Study of Electronic Record Management Systems in Taiwan

For e-government to succeed, government agencies must manage their records and archives of which the sheer volume and diversity necessitate the use of electronic record management systems (ERMS). Using an established business–technology alignment model, we analyze an agency’s strategic alignment choice and examine the outcomes and agency performance associated with that alignment. The specific research questions addressed in the study are as follows: (1) Do strategic alignment choices vary among agencies that differ in purpose or position within the overall government hierarchy? (2) Do agencies’ alignment choices lead to different outcomes? and (3) Does performance in implementing, operating, and using ERMS vary among agencies that follow different alignment choices? We conducted a large-scale survey study of 3,319 government agencies in Taiwan. Our data support the propositions tested. Based on the findings, we discuss their implications for digital government research and practice

Real-time bioprocess and automated feed control with in-line Raman sensor

Please click Additional Files below to see the full abstract

THE STRATEGIC CO-ALIGNMENT FOR IMPLEMENTING INFORMATION SYSTEMS IN E-GOVERNMENT

Regulating agency in government, i.e. regulator, must co-align its information systems (IS) planning strategy with executing agencies, i.e. executors, for better e-government performance. Using an established strategic co-alignment model, we analyze the mutual participating strategies between regulator and executors and examine the outcomes and performance associated with that co-alignment choice. After conducting a large-scale survey study of government agencies in Taiwan, the co-alignment relationship between e-government IS policy regulator and executor is examined. Based on the findings, we discuss their implications for e-government research and practice

Impacts of Light Rail Transit Tram on the Voltage and Unbalance of the Distribution System

This paper presents the three-phase voltage and unbalance analysis for the distribution system with the loading of a light rail transit (LRT) tram. To investigate the dynamic responses of the system voltage and current, this paper adopts the Alternative Transients Program (ATP) software to model and simulate a multigrounded four-wire distribution system with an LRT loading. Two different definitions about unbalance are used to evaluate the problem. In this paper, the traction supply substation (TSS) with a single-phase transformer configuration is designed first for providing the electric power to the trams of LRT. However, it may result in the significant neutral line current and unbalance phenomenon to deteriorate the power quality of the distribution system. A Le-Blanc connection transformer in the TSS is therefore proposed to solve the problems

FAM129B, an antioxidative protein, reduces chemosensitivity by competing with Nrf2 for Keap1 binding.

BackgroundThe transcription factor Nrf2 is a master regulator of antioxidant response. While Nrf2 activation may counter increasing oxidative stress in aging, its activation in cancer can promote cancer progression and metastasis, and confer resistance to chemotherapy and radiotherapy. Thus, Nrf2 has been considered as a key pharmacological target. Unfortunately, there are no specific Nrf2 inhibitors for therapeutic application. Moreover, high Nrf2 activity in many tumors without Keap1 or Nrf2 mutations suggests that alternative mechanisms of Nrf2 regulation exist.MethodsInteraction of FAM129B with Keap1 is demonstrated by immunofluorescence, colocalization, co-immunoprecipitation and mammalian two-hybrid assay. Antioxidative function of FAM129B is analyzed by measuring ROS levels with DCF/flow cytometry, Nrf2 activation using luciferase reporter assay and determination of downstream gene expression by qPCR and wester blotting. Impact of FAM129B on in vivo chemosensitivity is examined in mice bearing breast and colon cancer xenografts. The clinical relevance of FAM129B is assessed by qPCR in breast cancer samples and data mining of publicly available databases.FindingsWe have demonstrated that FAM129B in cancer promotes Nrf2 activity by reducing its ubiquitination through competition with Nrf2 for Keap1 binding via its DLG and ETGE motifs. In addition, FAM129B reduces chemosensitivity by augmenting Nrf2 antioxidative signaling and confers poor prognosis in breast and lung cancer.InterpretationThese findings demonstrate the important role of FAM129B in Nrf2 activation and antioxidative response, and identify FMA129B as a potential therapeutic target. FUND: The Chang Gung Medical Foundation (Taiwan) and the Ministry of Science and Technology (Taiwan)

Critical quality attributes (CQAs) of a therapeutic antibody produced from integrated continuous bioprocessing

The integrated continuous bioprocess provides an innovative way to produce protein drugs with flexibility and efficiency. However, during the long-term cultivation and complicated production, how to ensure the process stability and product quality is critically important. In this study, the monoclonal antibody (mAb) was produced in a bioreactor operated in a perfusion mode utilizing the ATF cell retention system for up to 32 days. The 2L harvest per day starting at day 10 was continuously purified using the 3-column periodic counter-current (PCC) chromatography system. The first protein A capture purification was performed with the dynamic binding capacity of 50% breakthrough around 60 mg mAb/mL of resin (vs 20 mg/mL resin for batch purification) for 120 cycles or 360 column operations followed by a polishing step of mixed mode chromatography for 20 cycles. The process and quality attributes were monitored daily. The results demonstrate consistency in both the purification process and the mAb qualities (in the aspects of product integrity, aggregates, and glycan profile) between PCC and batch purifications. Culture-related charge heterogeneity was observed accompanied by an increase of bioreactor harvest time using both batch and PCC purification processes. In addition, the impurities such as endotoxin and HCP were also monitored while under this high capacity utilization of chromatography resins. By sharing the insights of process and quality attributes, we hope to provide better understanding on the process-related heterogeneity between batch and continuous production and/or purification